ā Back to Trial
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Trial Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
- Contact: National Cancer Institute Referral Office Ā· 888-624-1937 Ā· [email protected] (opens in new tab)

